• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国慢性肾病患者队列研究中常染色体显性多囊肾病亚组的基线特征。

Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.

作者信息

Kim Hyunsuk, Koh Junga, Park Sue K, Oh Kook H, Kim Yeong H, Kim Yaeni, Ahn Curie, Oh Yun K

机构信息

Department of Internal Medicine, Hallym University Medical Center, Chuncheon Sacred Heart Hospital, Chuncheon, South Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

出版信息

Nephrology (Carlton). 2019 Apr;24(4):422-429. doi: 10.1111/nep.13407.

DOI:10.1111/nep.13407
PMID:29797773
Abstract

AIM

The aim of this study was to describe the baseline characteristics of autosomal-dominant polycystic kidney disease (ADPKD) in a cohort of Korean patients with chronic kidney disease (CKD).

METHODS

From April 2011 to February 2016, patients with CKD stage 1-5 (pre-dialysis) were enrolled as an ADPKD sub-cohort of the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease. Baseline characteristics, the correlation of kidney and liver volume and kidney function and the factors associated with kidney function were analysed.

RESULTS

A total of 364 ADPKD patients with a mean estimated glomerular filtration rate (eGFR) of 68.1 ± 33.3 mL/min per 1.73 m (50.5% male with a mean age of 47.0 ± 10.6 years) were enrolled from nine hospitals in Korea. Initially, 55.8% of the patients were asymptomatic, and pain was the most common symptom (12.9%); 87.6 and 77.5% of the patients had hypertension and hepatic cysts, respectively. The height-adjusted total kidney volumes (htTKV) were higher in male patients than in female patients. In contrast, the height-adjusted total liver volumes were higher in female patients than in male patients. The decrease rate of eGFR depending on Log(htTKV) was larger in the group aged between 41 and 50 years than the other age groups. Older age, a higher 24-h urine protein excretion, larger htTKV and hyperuricemia were independently associated with lower eGFR, whereas using febuxostat was independently associated with higher eGFR.

CONCLUSION

This sub-cohort will provide clinical characteristics and outcomes of Korean ADPKD patients, which can be compared with those of other previous cohorts. We have identified factors associated with advanced-stage CKD in Korean patients with ADPKD.

摘要

目的

本研究旨在描述一组韩国慢性肾脏病(CKD)患者中常染色体显性遗传性多囊肾病(ADPKD)的基线特征。

方法

2011年4月至2016年2月,CKD 1-5期(透析前)患者被纳入韩国慢性肾脏病患者结局队列研究的ADPKD亚组。分析了基线特征、肾脏和肝脏体积与肾功能的相关性以及与肾功能相关的因素。

结果

从韩国9家医院共纳入364例ADPKD患者,平均估计肾小球滤过率(eGFR)为68.1±33.3 mL/(min·1.73 m²)(50.5%为男性,平均年龄47.0±10.6岁)。最初,55.8%的患者无症状,疼痛是最常见的症状(12.9%);分别有87.6%和77.5%的患者患有高血压和肝囊肿。男性患者的身高校正后总肾体积(htTKV)高于女性患者。相反,女性患者的身高校正后总肝体积高于男性患者。41至50岁年龄组的eGFR随Log(htTKV)的下降率大于其他年龄组。年龄较大、24小时尿蛋白排泄量较高、htTKV较大和高尿酸血症与较低的eGFR独立相关,而使用非布司他与较高的eGFR独立相关。

结论

该亚组将提供韩国ADPKD患者的临床特征和结局,可与既往其他队列进行比较。我们已经确定了韩国ADPKD患者中与晚期CKD相关的因素。

相似文献

1
Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.韩国慢性肾病患者队列研究中常染色体显性多囊肾病亚组的基线特征。
Nephrology (Carlton). 2019 Apr;24(4):422-429. doi: 10.1111/nep.13407.
2
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.在常染色体显性多囊肾病中,基线总肾体积和肾脏生长速度与慢性肾脏病进展相关。
Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.
3
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.常染色体显性遗传多囊肾病患者在 CKD 1-4 期的健康相关生活质量:一项横断面研究。
Am J Kidney Dis. 2014 Feb;63(2):214-26. doi: 10.1053/j.ajkd.2013.08.017. Epub 2013 Nov 1.
4
Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.托伐普坦治疗日本晚期常染色体显性遗传性多囊肾病患者的效果。
J Nephrol. 2018 Dec;31(6):961-966. doi: 10.1007/s40620-018-0545-8. Epub 2018 Oct 24.
5
The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.亚洲多囊肾病患者肾脏体积与肾小球滤过率测定值的相关性:一项前瞻性队列研究。
BMC Nephrol. 2021 May 15;22(1):178. doi: 10.1186/s12882-021-02392-0.
6
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.图像纹理特征可预测常染色体显性多囊肾病患者的肾功能下降。
Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20.
7
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的肾脏体积和功能结局。
Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16.
8
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.尿血管紧张素原除影像学分类外,还可预测常染色体显性遗传性多囊肾病的肾脏结局。
J Korean Med Sci. 2020 Jun 8;35(22):e165. doi: 10.3346/jkms.2020.35.e165.
9
Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.用胱抑素C估算肾小球滤过率评估常染色体显性多囊肾病早期的肾功能。
PLoS One. 2017 Mar 27;12(3):e0174583. doi: 10.1371/journal.pone.0174583. eCollection 2017.
10
RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.RAPID-ADPKD(亚太地区常染色体显性遗传性多囊肾病快速进展患者的回顾性流行病学研究):一项多中心、回顾性队列研究的研究方案。
BMJ Open. 2020 Feb 6;10(2):e034103. doi: 10.1136/bmjopen-2019-034103.

引用本文的文献

1
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan.达格列净对接受托伐普坦治疗的常染色体显性多囊肾病患者疗效的开放标签、随机、对照、交叉试验
Kidney Int Rep. 2025 Jan 18;10(4):1063-1075. doi: 10.1016/j.ekir.2025.01.023. eCollection 2025 Apr.
2
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.40岁前发展至肾衰竭的常染色体显性多囊肾病患者的特征
Pediatr Nephrol. 2025 Jun;40(6):1997-2007. doi: 10.1007/s00467-024-06652-7. Epub 2025 Feb 1.
3
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.
黄嘌呤氧化还原酶在慢性肾脏病中的新作用
Antioxidants (Basel). 2024 Jun 12;13(6):712. doi: 10.3390/antiox13060712.
4
Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models.用尿酸酶抑制剂升高血清尿酸会使大鼠和小鼠模型中的多囊肾病恶化。
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1004-F1015. doi: 10.1152/ajprenal.00372.2023. Epub 2024 Apr 18.
5
Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease.突变是常染色体显性多囊肾病的生物标志物。
Biomolecules. 2023 Jun 21;13(7):1020. doi: 10.3390/biom13071020.
6
Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance.多囊肾病管理中的实际问题:血压与水平衡
Electrolyte Blood Press. 2022 Jun;20(1):10-16. doi: 10.5049/EBP.2022.20.1.10. Epub 2022 Jun 30.
7
Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study.梅奥影像分类是韩国常染色体显性多囊肾病患者快速进展的良好预测指标:KNOW-CKD研究结果
Kidney Res Clin Pract. 2022 Jul;41(4):432-441. doi: 10.23876/j.krcp.21.261. Epub 2022 Mar 3.
8
Stone Prevalence in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.常染色体显性多囊肾病中的结石患病率:一项系统评价和荟萃分析。
Can J Kidney Health Dis. 2020 Jul 4;7:2054358120934628. doi: 10.1177/2054358120934628. eCollection 2020.
9
Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients.韩国常染色体显性遗传性多囊肾病患者的临床和遗传学特征。
Korean J Intern Med. 2021 Jul;36(4):767-779. doi: 10.3904/kjim.2021.176. Epub 2021 Jul 1.
10
Ureteropelvic Junction Obstruction in a Polycystic Kidney with Duplicated System: Successful Outcome with Endoscopic Management.多囊肾合并重复系统的肾盂输尿管连接处梗阻:内镜治疗取得成功结果
J Endourol Case Rep. 2019 Aug 30;5(3):128-130. doi: 10.1089/cren.2019.0023. eCollection 2019.